These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 19556740)
41. [Efficacy of a cardioselective beta1-adrenoblocker bisoprolol in patients with chronic obstructive pulmonary disease in combination with ischemic heart disease]. Tsvetkova OA; Veselovskaia MV Ter Arkh; 2007; 79(3):25-9. PubMed ID: 17526191 [TBL] [Abstract][Full Text] [Related]
52. Genetic influences on right ventricular systolic pressure (RVSP) in chronic obstructive pulmonary disease (COPD). Shaw JG; Dent AG; Passmore LH; Burstow DJ; Bowman RV; Zimmerman PV; Fong KM; Yang IA BMC Pulm Med; 2012 Jun; 12():25. PubMed ID: 22695028 [TBL] [Abstract][Full Text] [Related]
53. Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension. Hoffmann J; Wilhelm J; Marsh LM; Ghanim B; Klepetko W; Kovacs G; Olschewski H; Olschewski A; Kwapiszewska G Am J Respir Crit Care Med; 2014 Jul; 190(1):98-111. PubMed ID: 24918967 [TBL] [Abstract][Full Text] [Related]
54. Role of vasoactive intestinal peptide in chronic obstructive pulmonary disease with pulmonary hypertension. Lacedonia D; Valerio G; Palladino GP; Carpagnano GE; Correale M; Di Biase M; Foschino Barbaro MP Rejuvenation Res; 2014 Feb; 17(1):33-9. PubMed ID: 24228853 [TBL] [Abstract][Full Text] [Related]
55. Genetic association of the serotonin transporter in pulmonary arterial hypertension. Machado RD; Koehler R; Glissmeyer E; Veal C; Suntharalingam J; Kim M; Carlquist J; Town M; Elliott CG; Hoeper M; Fijalkowska A; Kurzyna M; Thomson JR; Gibbs SR; Wilkins MR; Seeger W; Morrell NW; Gruenig E; Trembath RC; Janssen B Am J Respir Crit Care Med; 2006 Apr; 173(7):793-7. PubMed ID: 16399993 [TBL] [Abstract][Full Text] [Related]
56. Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension. Willers ED; Newman JH; Loyd JE; Robbins IM; Wheeler LA; Prince MA; Stanton KC; Cogan JA; Runo JR; Byrne D; Humbert M; Simonneau G; Sztrymf B; Morse JA; Knowles JA; Roberts KE; McElroy JJ; Barst RJ; Phillips JA Am J Respir Crit Care Med; 2006 Apr; 173(7):798-802. PubMed ID: 16339917 [TBL] [Abstract][Full Text] [Related]
57. Association of brain natriuretic peptide gene polymorphisms with chronic obstructive pulmonary disease complicated with pulmonary hypertension and its mechanism. Jin G; Chen Z; Zhang J; Song J; Shi J; Zhou B Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30217946 [No Abstract] [Full Text] [Related]
58. Nitric oxide synthase 3 and endothelin 1 immunoreactivity in pulmonary hypertension. Gupta RK; Vaideeswar P Indian J Pathol Microbiol; 2010; 53(3):447-50. PubMed ID: 20699500 [TBL] [Abstract][Full Text] [Related]
59. Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension. Frille A; Rullmann M; Becker GA; Patt M; Luthardt J; Tiepolt S; Wirtz H; Sabri O; Hesse S; Seyfarth HJ Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1081-1092. PubMed ID: 33009594 [TBL] [Abstract][Full Text] [Related]
60. Serotonergic gene polymorphisms (5-HTTLPR, 5HTR1A, 5HTR2A), and population differences in aggression: traditional (Hadza and Datoga) and industrial (Russians) populations compared. Butovskaya ML; Butovskaya PR; Vasilyev VA; Sukhodolskaya JM; Fekhredtinova DI; Karelin DV; Fedenok JN; Mabulla AZP; Ryskov AP; Lazebny OE J Physiol Anthropol; 2018 Apr; 37(1):10. PubMed ID: 29661255 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]